{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:46:45Z","timestamp":1790970405188,"version":"4.1.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T00:00:00Z","timestamp":1475712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0162368","type":"journal-article","created":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T17:59:30Z","timestamp":1475776770000},"page":"e0162368","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":108,"title":["Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1371","volume":"11","author":[{"given":"Xi-Xi","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Pin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-Jiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,10,6]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/obr.12407","article-title":"Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies","volume":"17","author":"L Li","year":"2016","journal-title":"Obes Rev"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1590\/S1516-31802007000600006","article-title":"Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults","volume":"125","author":"M Karnikowski","year":"2007","journal-title":"Sao Paulo Med J"},{"issue":"2","key":"ref3","first-page":"229","article-title":"Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease","volume":"136","author":"R Kumar","year":"2012","journal-title":"Indian J Med Res"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ps\/79.7.961","article-title":"Human requirement for N-3 polyunsaturated fatty acids","volume":"79","author":"AP Simopoulos","year":"2000","journal-title":"Poult Sci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000327785","article-title":"Importance of the omega-6\/omega-3 balance in health and disease: evolutionary aspects of diet","volume":"102","author":"AP Simopoulos","year":"2011","journal-title":"World Rev Nutr Diet"},{"issue":"1\u20132","key":"ref6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2298\/MPNS0302050R","article-title":"Role and importance of dietary polyunsaturated fatty acids in the prevention and therapy of atherosclerosis","volume":"56","author":"V Ristic","year":"2003","journal-title":"Med Pregl"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1042\/CS20030326","article-title":"Increase in long-chain polyunsaturated fatty acid n\u20146\/n\u20143 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease","volume":"106","author":"J Araya","year":"2004","journal-title":"Clinical science (London, England: 1979)"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cct.2014.02.002","article-title":"Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected]","volume":"37","author":"E Scorletti","year":"2014","journal-title":"Contemp Clin Trials"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2431-13-85","article-title":"Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial","volume":"13","author":"W Janczyk","year":"2013","journal-title":"BMC Pediatr"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MCG.0000000000000099","article-title":"Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis","volume":"49","author":"S Dasarathy","year":"2015","journal-title":"J Clin Gastroenterol"},{"issue":"SUPPL. 1","key":"ref11","article-title":"Effects of omega-3 polyunsaturated fatty acids (PUFA) from fish and flaxseed oils on nonalcoholic steatohepatitis (NASH)","volume":"58","author":"M.A. AVAF Nogueira","year":"2013","journal-title":"Journal of Hepatology"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/j.gastro.2014.04.046","article-title":"No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial","volume":"147","author":"AJ Sanyal","year":"2014","journal-title":"Gastroenterology"},{"key":"ref13","article-title":"Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial","author":"MA Nogueira","year":"2015","journal-title":"Clin Nutr"},{"issue":"3","key":"ref14","first-page":"e123","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"3","author":"D Moher","year":"2009","journal-title":"Open Med"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3109\/09637486.2010.487480","article-title":"Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study","volume":"61","author":"F Sofi","year":"2010","journal-title":"Int J Food Sci Nutr"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.dld.2007.10.003","article-title":"Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease","volume":"40","author":"L Spadaro","year":"2008","journal-title":"Dig Liver Dis"},{"issue":"41","key":"ref17","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.3748\/wjg.14.6395","article-title":"Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia","volume":"14","author":"FS Zhu","year":"2008","journal-title":"World J Gastroenterol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.11569\/wcjd.v16.i18.2002","article-title":"Therapeutic efficacy of (omega)-3 polyunsaturated fatty acid capsule in treatment of patients with non-alcoholic fatty liver disease","volume":"16","author":"GQ Chen R","year":"2008","journal-title":"World Chin J Digestol"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.27289","article-title":"Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study","volume":"60","author":"E Scorletti","year":"2014","journal-title":"Hepatology"},{"issue":"22","key":"ref20","doi-asserted-by":"crossref","first-page":"7008","DOI":"10.3748\/wjg.v21.i22.7008","article-title":"Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis","volume":"21","author":"YH Li","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jhep.2014.08.036","article-title":"Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial","volume":"62","author":"CK Argo","year":"2015","journal-title":"J Hepatol"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","article-title":"Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"56","author":"HM Parker","year":"2012","journal-title":"J Hepatol"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease","volume":"52","author":"G Musso","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1478-3231.2012.02807.x","article-title":"Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites","volume":"33","author":"P Angeli","year":"2013","journal-title":"Liver Int"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbacli.2015.05.001","article-title":"Effect of caloric restriction with or without n-3 polyunsaturated fatty acids on insulin sensitivity in obese subjects: A randomized placebo controlled trial","volume":"4","author":"U Razny","year":"2015","journal-title":"BBA Clin"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep.20920","article-title":"Insulin resistance: a metabolic pathway to chronic liver disease","volume":"42","author":"E Bugianesi","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1590-8658(03)00025-2","article-title":"Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis","volume":"35","author":"L Valenti","year":"2003","journal-title":"Dig Liver Dis"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12020-014-0247-5","article-title":"Identification and validation co-differentially expressed genes with NAFLD and insulin resistance","volume":"48","author":"XC Wang","year":"2015","journal-title":"Endocrine"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1210\/en.2012-1368","article-title":"Overexpression of the adiponectin receptor AdipoR1 in rat skeletal muscle amplifies local insulin sensitivity","volume":"153","author":"SA Patel","year":"2012","journal-title":"Endocrinology"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/liv.12500","article-title":"n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis","volume":"34","author":"A Provenzano","year":"2014","journal-title":"Liver Int"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1756283X13484078","article-title":"Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial","volume":"6","author":"C Eckard","year":"2013","journal-title":"Therap Adv Gastroenterol"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/MCO.0b013e3283566614","article-title":"Improving dietary patterns in patients with nonalcoholic fatty liver disease","volume":"15","author":"S Carvalhana","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"22","key":"ref33","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"R Belfort","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","article-title":"Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis","volume":"135","author":"GP Aithal","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.20452\/pamw.1023","article-title":"Rosiglitazone treatment in nondiabetic subjects with nonalcoholic fatty liver disease","volume":"121","author":"M Saryusz-Wolska","year":"2011","journal-title":"Pol Arch Med Wewn"},{"issue":"9285","key":"ref36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(01)06042-1","article-title":"Metformin in non-alcoholic steatohepatitis","volume":"358","author":"G Marchesini","year":"2001","journal-title":"Lancet (London, England)"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/1735-9066.174759","article-title":"The effect of vitamin D supplementation on blood sugar and different indices of insulin resistance in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"21","author":"M Foroughi","year":"2016","journal-title":"Iranian journal of nursing and midwifery research"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/j.1572-0241.2003.08699.x","article-title":"Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis","volume":"98","author":"SA Harrison","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/HMER.S41258","article-title":"Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study","volume":"5","author":"M Kawanaka","year":"2013","journal-title":"Hepat Med"},{"issue":"12","key":"ref40","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","author":"DL White","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"ZM Younossi","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/adc.2010.192401","article-title":"Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial","volume":"96","author":"V Nobili","year":"2011","journal-title":"Arch Dis Child"},{"issue":"10","key":"ref43","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1089\/jmf.2013.0043","article-title":"The I148M variant of PNPLA3 reduces the response to docosahexaenoic acid in children with non-alcoholic fatty liver disease","volume":"16","author":"V Nobili","year":"2013","journal-title":"J Med Food"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.numecd.2012.10.010","article-title":"Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children","volume":"23","author":"V Nobili","year":"2013","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jpeds.2015.01.056","article-title":"Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial","volume":"166","author":"W Janczyk","year":"2015","journal-title":"J Pediatr"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2016.01.016","article-title":"Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up","volume":"246","author":"AL Fracanzani","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref47","article-title":"Non-alcoholic fatty liver disease and risk of cardiovascular disease","author":"A Lonardo","year":"2015","journal-title":"Metabolism"},{"issue":"5","key":"ref48","first-page":"561","article-title":"Omega-3 polyunsaturated fatty acids and cardiovascular diseases","volume":"51","author":"R Marchioli","year":"2003","journal-title":"Minerva Cardioangiol"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"e0157580","DOI":"10.1371\/journal.pone.0157580","article-title":"Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice","volume":"11","author":"N Suzuki-Kemuriyama","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"ref50","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3945\/an.115.009423","article-title":"Potential for dietary omega-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer","volume":"6","author":"DB Jump","year":"2015","journal-title":"Adv Nutr"},{"issue":"4","key":"ref51","first-page":"131","article-title":"Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia","volume":"23","author":"A Hatzitolios","year":"2004","journal-title":"Indian J Gastroenterol"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MCG.0b013e31815591aa","article-title":"Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis","volume":"42","author":"N Tanaka","year":"2008","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"ref53","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-2036.2006.02885.x","article-title":"Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study","volume":"23","author":"M Capanni","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/liv.12500","article-title":"n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis","volume":"34","author":"A Provenzano","year":"2014","journal-title":"Liver Int"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17030375","article-title":"Expression and Sequence Variants of Inflammatory Genes; Effects on Plasma Inflammation Biomarkers Following a 6-Week Supplementation with Fish Oil","volume":"17","author":"H Cormier","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"7","key":"ref56","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.2337\/dc14-3101","article-title":"Effects of Dietary n-3 Fatty Acids on Hepatic and Peripheral Insulin Sensitivity in Insulin-Resistant Humans","volume":"38","author":"AZ Lalia","year":"2015","journal-title":"Diabetes Care"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0162368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T02:05:16Z","timestamp":1749607516000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0162368"}},"subtitle":[],"editor":[{"given":"Jonathan M","family":"Peterson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,6]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0162368","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,6]]}}}